Search
for
Sort by
Research 121–150 of 1000+
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Biotinidase Deficiency: Prevalence, Impact And Management Strategies.
- Ban Tu Wan hepatotoxicity
- The COVID-19 pandemic and its skin effects
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- A Case Study on Demodicosis in Golden Retriever
- Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Case report: Acrodermatitis enteropathica result from a novel SLC39A4 gene mutation
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy
- Cutaneous manifestations associated with substance use disorders
- Acquired immunogenicity of DNA after modification with malondialdehyde in patients with alopecia areata
- Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata
- Geriatric Dermatology: Overview
- Current management strategies for cutaneous T-cell lymphoma
- Therapeutic Effect of Rumex japonicus Houtt. on DNCB-Induced Atopic Dermatitis-Like Skin Lesions in Balb/c Mice and Human Keratinocyte HaCaT Cells
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- A 25-year-old female with a variable presentation of MCTD-A case report
- Isoniazid-induced alopecia
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- 31-Year-Old Woman With Alopecia
- Dermatological Manifestations of COVID-19 Patients
- Granulation Tissue that Developed after a Minor Trauma in a Psoriatic Patient on Long-term Etretinate Therapy